WALTHAM, Mass.--(BUSINESS WIRE)--Jun 12, 2024-- To support the future implementation of workflow automation in cell therapy production, Thermo Fisher Scientific introduces the Thermo ScientificTM HeracellTM VIOSTM 250i AxD CO 2 Incubators. These first-of-their-kind CO 2 incubators are designed for integration into automated and modular laboratories.
The VIOS family of incubators are known for optimal cell growth conditions and minimal contamination risk. Now adding the innovation of patent-pending automated door control, the Heracell VIOS AxD CO 2 incubator opens automatically when integrated into a centralized lab automation platform, allowing vessel loading and unloading through robotic control and supporting continuous cell therapy production processes. This press release features multimedia.
View the full release here: https://www.businesswire.com/news/home/20240612688960/en/ First-of-its-kind innovation for CO2 Incubators delivers new features compatible with lab automation, supporting emerging automated cell therapy production processes (Photo: Business Wire) Emerging cell therapy manufacturers, biotech and pharmaceutical companies focused on bringing advanced therapies to market want to automate production of cultured cells without compromising quality.
The new innovative design of the Heracell VIOS Incubator modernizes cell therapy production without compromising on contamination control features. “Human handling and complex processes limit broad availability of cut.